{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T20:19:00Z","timestamp":1700770740004},"reference-count":31,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T00:00:00Z","timestamp":1132617600000},"content-version":"vor","delay-in-days":10371,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1977,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cyclophosphamide (Cy) has been demonstrated to be effective in treating autoimmune disease in NZB\/NZW F<jats:sub>1<\/jats:sub> mice. This study was designed to compare the efficacy of chlorambucil (Chlor) with that of a known effective drug (Cy) in the treatment of murine lupus. NZB\/W female mice were treated with Cy, Chlor, or nothing on a once\u2010a\u2010month dosage schedule. The age of onset of proteinuria, the severity of glomerular lesions, and the median survival were compared among the three treatment groups. Cy was found to be superior to Chlor and controls in all measures.<\/jats:p>","DOI":"10.1002\/art.1780200615","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T18:01:31Z","timestamp":1171476091000},"page":"1263-1268","source":"Crossref","is-referenced-by-count":6,"title":["Therapeutic Studies in NZB\/NZW F<sub>1<\/sub> Mice"],"prefix":"10.1002","volume":"20","author":[{"given":"N. Lynn","family":"Gerber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred D.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,11,22]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-65848-8_3"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(66)91198-6"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(68)92778-5"},{"key":"e_1_2_1_5_2","first-page":"48","article-title":"Carcinogenic effect of azathioprine in young NZB\/Bl and NZB \u00d7 NZW mice","volume":"45","author":"Casey TP","year":"1967","journal-title":"Proc Univ Otago Med Sch"},{"key":"e_1_2_1_6_2","first-page":"390","article-title":"Systemic lupus erythematosus in NZB \u00d7 NZW hybrid mice treated with the corticosteroid drug betamethasone","volume":"71","author":"Casey TP","year":"1968","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/blood.V32.3.436.436","article-title":"Immunosuppression by cyclophosphamide in NZB \u00d7 NZW mice with lupus nephritis","volume":"32","author":"Casey TP","year":"1968","journal-title":"Blood"},{"key":"e_1_2_1_8_2","first-page":"199","article-title":"Cyclophosphamide treatment of mouse systemic lupus erythematosus","volume":"21","author":"Horowitz RE","year":"1969","journal-title":"Lab Invest"},{"key":"e_1_2_1_9_2","first-page":"619","article-title":"Augmented incidence of neoplasia in NZB\/NZW mice treated with long\u2010term cyclophosphamide","volume":"82","author":"Walker SE","year":"1973","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_10_2","first-page":"119","article-title":"Mechanisms and quantitation of reduction in NZB\/NZW nephritis by cyclophosphamide","volume":"15","author":"Morris AD","year":"1972","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780160205"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780150304"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780150305"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780180102"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-75-2-165"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-76-4-619"},{"key":"e_1_2_1_17_2","volume-title":"Urinary sediment in acute diffuse lupus erythematosus: nature and response to treatment","author":"Dustan HP","year":"1951"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-195308000-00009"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1954.00240290025003"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5860.197"},{"key":"e_1_2_1_21_2","first-page":"641","article-title":"The use of chlorambucil in the treatment of systemic lupus erythematosus","volume":"2","author":"McIlvanie SK","year":"1965","journal-title":"Proc IX Cong Int Soc Hematol"},{"key":"e_1_2_1_22_2","first-page":"493","article-title":"A simple method of estimating fifty percent endpoint","volume":"27","author":"Reed LJ","year":"1938","journal-title":"Am J Hyg"},{"key":"e_1_2_1_23_2","first-page":"628","article-title":"The pathogenesis of autoimmunity in New Zealand mice. II. Acceleration of glomerulonephritis by polyinosinic polycytidilic acid","volume":"23","author":"Carpenter DF","year":"1970","journal-title":"Lab Invest"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(64)90141-9"},{"key":"e_1_2_1_25_2","first-page":"65","article-title":"Dose\u2010response relationships for agents inhibiting the immune response","volume":"7","author":"Berenbaum MC","year":"1964","journal-title":"Immunology"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000229713"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197102112840602"},{"key":"e_1_2_1_28_2","first-page":"671","article-title":"A laboratory model for Sj\u00f6gren's syndrome","volume":"52","author":"Kessler HS","year":"1968","journal-title":"Am J Pathol"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780190107"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.167.3919.870"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000231311"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4049\/jimmunol.107.2.359","article-title":"Inability of the NZB\/NZW F1 thymus to transfer cyclophosphamide\u2010induced tolerance to sheep erythrocytes","volume":"107","author":"Jacobs ME","year":"1971","journal-title":"J Immunol"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780200615","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780200615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T11:46:46Z","timestamp":1700740006000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780200615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1977,7]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1977,7]]}},"alternative-id":["10.1002\/art.1780200615"],"URL":"https:\/\/doi.org\/10.1002\/art.1780200615","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1977,7]]}}}